Merck & Co., Inc. (MRK): A Bull Case Theory

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Disruptive analytics’s Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc. (MRK)'s share was trading at $103.73 as of Oct 29^th. MRK’s trailing and forward P/E were 19.21 and 10.34 respectively according to Yahoo Finance.

[caption id="attachment_1235572" align="aligncenter" width="768"] A pharmaceutical sales rep holding a medicine pack, highlighting the drug candidate products.[/caption]

Merck & Co., Inc. operates as a healthcare company worldwide it faces a...